Thromboprophylaxis Medication is used to prevent blood clots in patients undergoing liver resection surgery. This medication helps reduce the risk of venous thromboembolism, which is a condition where blood clots form in the veins. The goal is to start this medication around the time of surgery to protect patients from developing these potentially dangerous clots without increasing the risk of bleeding.

Venous Thromboembolism – This condition involves the formation of blood clots in the veins, which can lead to complications if the clots travel to the lungs or other parts of the body. It typically begins with a clot forming in a deep vein, often in the legs, known as deep vein thrombosis. If the clot dislodges, it can travel to the lungs, causing a pulmonary embolism. Symptoms may include swelling, pain, and redness in the affected area, as well as difficulty breathing if the lungs are involved. The condition can develop after surgery, prolonged immobility, or due to certain medical conditions. Early detection and management are crucial to prevent further complications.

Posthepatectomy Hemorrhage – This condition refers to bleeding that occurs after liver surgery, which can vary in severity. It may happen immediately after the operation or within a few days. The bleeding can be due to surgical complications or issues with blood clotting. Symptoms might include a drop in blood pressure, increased heart rate, and signs of blood loss such as pallor or fatigue. Monitoring and managing blood loss are important to ensure recovery. The condition is assessed using specific classifications to determine its severity and impact on the patient.